Chen et al. [108] proposed another mixture of therapeutic agents of metformin—originally an antidiabetic drug—and DHA—an Omega 3 polyunsaturated fatty acid—that would suppress tumor metastasis by inhibiting NF-κB signal pathway and STAT3 pathways, changing the tumor inflammatory microenvironment. The gene discussed is STAT3; the disease is neoplasm.